169 related articles for article (PubMed ID: 11948556)
1. Amphotericin B in oil-water lecithin-based microemulsions: formulation and toxicity evaluation.
Brime B; Moreno MA; Frutos G; Ballesteros MP; Frutos P
J Pharm Sci; 2002 Apr; 91(4):1178-85. PubMed ID: 11948556
[TBL] [Abstract][Full Text] [Related]
2. Lyophilized lecithin based oil-water microemulsions as a new and low toxic delivery system for amphotericin B.
Moreno MA; Frutos P; Ballesteros MP
Pharm Res; 2001 Mar; 18(3):344-51. PubMed ID: 11442275
[TBL] [Abstract][Full Text] [Related]
3. Lecithin-based oil-in-water microemulsions for parenteral use: pseudoternary phase diagrams, characterization and toxicity studies.
Moreno MA; Ballesteros MP; Frutos P
J Pharm Sci; 2003 Jul; 92(7):1428-37. PubMed ID: 12820147
[TBL] [Abstract][Full Text] [Related]
4. Oil-in-water lecithin-based microemulsions as a potential delivery system for amphotericin B.
Pestana KC; Formariz TP; Franzini CM; Sarmento VH; Chiavacci LA; Scarpa MV; Egito ES; Oliveira AG
Colloids Surf B Biointerfaces; 2008 Oct; 66(2):253-9. PubMed ID: 18676122
[TBL] [Abstract][Full Text] [Related]
5. Amphiphilic association systems for Amphotericin B delivery.
Esposito E; Bortolotti F; Menegatti E; Cortesi R
Int J Pharm; 2003 Jul; 260(2):249-60. PubMed ID: 12842344
[TBL] [Abstract][Full Text] [Related]
6. Development of oil-in-water microemulsions for the oral delivery of amphotericin B.
Silva AE; Barratt G; Chéron M; Egito ES
Int J Pharm; 2013 Oct; 454(2):641-8. PubMed ID: 23726904
[TBL] [Abstract][Full Text] [Related]
7. Comparative pharmacokinetics and safety of a novel lyophilized amphotericin B lecithin-based oil-water microemulsion and amphotericin B deoxycholate in animal models.
Brime B; Frutos P; Bringas P; Nieto A; Ballesteros MP; Frutos G
J Antimicrob Chemother; 2003 Jul; 52(1):103-9. PubMed ID: 12805269
[TBL] [Abstract][Full Text] [Related]
8. Formulation and evaluation of microemulsion based delivery system for amphotericin B.
Darole PS; Hegde DD; Nair HA
AAPS PharmSciTech; 2008; 9(1):122-8. PubMed ID: 18446472
[TBL] [Abstract][Full Text] [Related]
9. Getting the Jump on the Development of Bullfrog Oil Microemulsions: a Nanocarrier for Amphotericin B Intended for Antifungal Treatment.
Oliveira WN; Amaral-Machado L; Alencar EN; Marcelino HR; Genre J; Silva-Rocha WP; Gondim AD; Chaves GM; Fernandes-Pedrosa MF; Egito EST
AAPS PharmSciTech; 2018 Aug; 19(6):2585-2597. PubMed ID: 29916194
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation.
Gangadhar KN; Adhikari K; Srichana T
Int J Pharm; 2014 Aug; 471(1-2):430-8. PubMed ID: 24907597
[TBL] [Abstract][Full Text] [Related]
11. Structural properties induced by the composition of biocompatible phospholipid-based microemulsion and amphotericin B association.
Franzini CM; Pestana KC; Molina EF; Scarpa MV; do Egito ES; de Oliveira AG
J Biomed Nanotechnol; 2012 Apr; 8(2):350-9. PubMed ID: 22515088
[TBL] [Abstract][Full Text] [Related]
12. Solubility of amphotericin B in water-lecithin-dispersions and lecithin-based submicron emulsions.
Salerno C; Perez S; Monteagudo E; Carlucci A; Bregni C
Pak J Pharm Sci; 2013 Jan; 26(1):189-93. PubMed ID: 23261747
[TBL] [Abstract][Full Text] [Related]
13. Ascorbyl dipalmitate/PEG-lipid nanoparticles as a novel carrier for hydrophobic drugs.
Moribe K; Maruyama S; Inoue Y; Suzuki T; Fukami T; Tomono K; Higashi K; Tozuka Y; Yamamoto K
Int J Pharm; 2010 Mar; 387(1-2):236-43. PubMed ID: 20005934
[TBL] [Abstract][Full Text] [Related]
14. Study of the toxicity of a new lipid complex formulation of amphotericin B.
Larabi M; Pages N; Pons F; Appel M; Gulik A; Schlatter J; Bouvet S; Barratt G
J Antimicrob Chemother; 2004 Jan; 53(1):81-8. PubMed ID: 14657087
[TBL] [Abstract][Full Text] [Related]
15. Formulation and optimization of nanoemulsion using antifungal lipid and surfactant for accentuated topical delivery of Amphotericin B.
Hussain A; Singh VK; Singh OP; Shafaat K; Kumar S; Ahmad FJ
Drug Deliv; 2016 Oct; 23(8):3101-3110. PubMed ID: 27854145
[TBL] [Abstract][Full Text] [Related]
16. In-vitro and in-vivo antileishmanial activity of inexpensive Amphotericin B formulations: Heated Amphotericin B and Amphotericin B-loaded microemulsion.
Rochelle do Vale Morais A; Silva AL; Cojean S; Balaraman K; Bories C; Pomel S; Barratt G; do Egito EST; Loiseau PM
Exp Parasitol; 2018 Sep; 192():85-92. PubMed ID: 30075233
[TBL] [Abstract][Full Text] [Related]
17. Formulation of parenteral microemulsion containing itraconazole.
Rhee YS; Park CW; Nam TY; Shin YS; Chi SC; Park ES
Arch Pharm Res; 2007 Jan; 30(1):114-23. PubMed ID: 17328251
[TBL] [Abstract][Full Text] [Related]
18. Lecithin-based microemulsion of a peptide for oral administration: preparation, characterization, and physical stability of the formulation.
Cilek A; Celebi N; Tirnaksiz F
Drug Deliv; 2006; 13(1):19-24. PubMed ID: 16401589
[TBL] [Abstract][Full Text] [Related]
19. Formulation of a cosurfactant-free O/W microemulsion using nonionic surfactant mixtures.
Cho YH; Kim S; Bae EK; Mok CK; Park J
J Food Sci; 2008 Apr; 73(3):E115-21. PubMed ID: 18387105
[TBL] [Abstract][Full Text] [Related]
20. Comparative therapeutic efficacy of a novel lyophilized amphotericin B lecithin-based oil-water microemulsion and deoxycholate-amphotericin B in immunocompetent and neutropenic mice infected with Candida albicans.
Brime B; Molero G; Frutos P; Frutos G
Eur J Pharm Sci; 2004 Aug; 22(5):451-8. PubMed ID: 15265515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
